Diltiazem hydrochloride
Oxycardil 120 is a medicine containing 120 mg of diltiazem hydrochloride. Oxycardil 120 belongs to a group of medicines called calcium antagonists. These medicines act on the smooth muscles of blood vessels and have a strong effect on the heart muscle. Oxycardil 120 is indicated for the treatment of:
Before starting treatment with Oxycardil 120, the patient should discuss it with their doctor or pharmacist,
Taking Oxycardil 120 may be associated with mood changes, including depression.
Tablets should be taken without chewing, before meals, washed down with a sufficient amount of liquid (e.g. one glass of water).
If the patient is pregnant or breastfeeding, thinks they may be pregnant or plans to have a child, they should consult their doctor before taking this medicine. The use of Oxycardil 120 is contraindicated during pregnancy, as well as in women of childbearing age who do not use effective contraception methods. In case of necessity to use Oxycardil 120 in breastfeeding women, an alternative method of feeding the child should be used.
Based on the collected adverse reactions, i.e. dizziness (frequent), malaise (frequent), the ability to drive vehicles and operate machines may be impaired, but no studies have been conducted in this regard.
The patient should tell their doctor about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take. Oxycardil 120 may enhance the effects of other medicines taken at the same time. The doctor should be informed if the patient is taking the following medicines:
Oxycardil 120 contains lactose and sucrose; if the patient has previously been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medicine.
Oxycardil 120 contains hydrogenated castor oil: the medicine may cause gastrointestinal disorders and diarrhoea.
This medicine should always be taken according to the doctor's instructions. In case of doubts, the patient should consult their doctor.
The following dosage schedule is recommended for adults.
Ischaemic heart disease
In ischaemic heart disease, 180-360 mg of diltiazem hydrochloride is usually taken per day in 1 or 2 divided doses. The maximum recommended daily dose is 360 mg. In case of long-term treatment with a satisfactory clinical effect, it is recommended to check every 2-3 months whether it is possible to reduce the dose of the medicine.
Hypertension
Depending on the individual patient's condition, 120-360 mg of diltiazem hydrochloride is usually taken per day in 1 or 2 divided doses. The maximum recommended daily dose is 360 mg. In case of achieving a satisfactory antihypertensive effect, it is worth considering the possibility of reducing the dose of the medicine.
The safety and efficacy of Oxycardil 120 in children have not been established.
In patients with hepatic and/or renal impairment, the medicine may only be used with caution, especially when increasing the dose. Liver and kidney function should be regularly assessed.
In elderly patients, the medicine may only be used with caution, especially when increasing the dose. Treatment should be started with a dose of 60 mg (in the form of coated tablets, 2-3 times a day).
Overdose of Oxycardil 120 may lead to severe hypotension (including shock), bradycardia, heart failure, atrioventricular block, or worsening of kidney function.
In case of taking a higher than recommended dose of Oxycardil 120, the patient should immediately consult their doctor. Depending on the symptoms, the doctor will administer appropriate treatment.
In case the patient forgets to take Oxycardil 120, they should take it as soon as possible, unless it is almost time for the next dose. In this case, the patient should take the next dose at the scheduled time. A double dose should not be taken to make up for a missed dose.
Oxycardil 120 is used for long-term treatment. Stopping treatment or changing the dosage of the medicine should only be done under medical supervision.
If treatment with Oxycardil 120 is to be stopped, the medicine should be discontinued gradually, reducing the subsequent doses, especially in patients with ischaemic heart disease.
Like all medicines, Oxycardil 120 can cause side effects, although not everybody gets them. The frequency of side effects is presented in accordance with the MedDRA convention: very common (≥1/10); common (≥1/100 to <1>Blood and lymphatic system disorders:
Not known: thrombocytopenia
Psychiatric disorders:
Uncommon: nervousness, insomnia
Not known: mood changes (including depression)
Nervous system disorders:
Common: headache, dizziness
Not known: extrapyramidal symptoms, myoclonus (muscle twitching)
Cardiac disorders:
Common: atrioventricular block (first, second or third degree, possible bundle branch block), palpitations
Uncommon: bradycardia (reduced heart rate)
Not known: sinoatrial block, congestive heart failure
Vascular disorders:
Common: flushing, especially of the face
Uncommon: orthostatic hypotension
Not known: vasculitis (including leukocytoclastic vasculitis)
Gastrointestinal disorders:
Common: constipation, nausea, abdominal pain, vomiting
Uncommon: diarrhoea
Rare: dryness of the oral mucosa
Not known: gingival hyperplasia
Hepatobiliary disorders:
Uncommon: increased liver enzyme activity (ASAT, ALAT, LDH, alkaline phosphatase)
Not known: hepatitis
Skin and subcutaneous tissue disorders:
Common: rash
Rare: urticaria
Not known: photosensitivity (including solar dermatitis), angioedema, erythema multiforme (including Stevens-Johnson syndrome and toxic epidermal necrolysis), sweating, exfoliative dermatitis, acute generalized exanthematous pustulosis, rare erythema multiforme with or without fever, a condition in which the immune system attacks the body's own tissues, causing symptoms such as joint swelling, fatigue and rash (known as "lupus-like syndrome").
Reproductive system and breast disorders:
Not known: gynaecomastia
General disorders and administration site conditions:
Very common: peripheral oedema
Common: malaise
If the patient experiences any side effects, including any side effects not listed in the leaflet, they should tell their doctor, pharmacist or nurse. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices and Biocidal Products, Al. Jerozolimskie 181 C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorisation holder. By reporting side effects, more information can be collected on the safety of the medicine.
Store in a temperature below 25°C.
The medicine should be stored out of sight and reach of children.
Do not use this medicine after the expiry date stated on the carton. The expiry date refers to the last day of the month stated.
The packaging contains 30, 60 or 100 tablets.
Not all pack sizes may be marketed.
Marketing authorisation holder
VEDIM Sp. z o.o.
ul. Kruczkowskiego 8
00-380 Warsaw
Tel.: + 48 22 696 99 20
Manufacturer:
Orifarm Manufacturing Poland Sp. z o.o.
ul. Księstwa Łowickiego 12
99-420 Łyszkowice
Date of last revision of the leaflet:April 2023
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.